Obermatt
See Similar Stocks →

Oric Pharmaceuticals

NSQ:ORIC · US68622P1093
BiotechnologySmall

360° View

no current rank
Price/Sales—
Price/Earnings51
Price/Book59
Dividend Yield—
Revenue Growth—
Profit Growth45
Capital Growth31
TSR 52w8
Leverage61
Liquidity53
Refinancing57
Combined—
Analyst Opinions64
Pro Holdings97
Opinion Changes81
Market Pulse59

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded2014
Employees100
Websiteoricpharma.com
ISINUS68622P1093
Last UpdateApr 2, 2026
Index & Theme
OncologyBiotechnologyHealth CarePharmaceuticalTherapeutics

Description

ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to improving patients’ lives by overcoming resistance in cancer. The company’s fully integrated research and development team is advancing a diverse pipeline of clini…

Similar Stocks

The companies this stock is ranked against.

Compare Oric Pharmaceuticals with its peers
Nuvalent
NSQ:NUVL
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Immuneering
NMQ:IMRX
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Oncolytics Biotech
NAQ:ONCY
—
CountryCanada
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
Celcuity
NAQ:CELC
96
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Acrivon Therapeutics
NMQ:ACRV
6
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Zymeworks
NSQ:ZYME
43
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →